CD36, a member of the class B scavenger receptor family, as a receptor for advanced glycation end products

被引:189
作者
Ohgami, N
Nagai, R
Ikemoto, M
Arai, H
Kuniyasu, A
Horiuchi, S
Nakayama, H
机构
[1] Kumamoto Univ, Sch Med, Dept Biochem, Kumamoto 8600811, Japan
[2] Kumamoto Univ, Fac Pharmaceut Sci, Dept Biofunct Chem, Kumamoto 8620973, Japan
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan
[4] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan
关键词
D O I
10.1074/jbc.M006545200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interaction of advanced glycation end products (AGE) with AGE receptors induces several cellular phenomena potentially relating to diabetic complications. Five AGE receptors identified so far are RAGE (receptor for AGE), galectin-3, 80K-H, OST-48, and SRA (macrophage Scavenger receptor class A types I and II). Since SRA is known to belong to the class A scavenger receptor family, and the scavenger receptor collectively represents a family of multiligand lipoprotein receptors, it is possible that CD36, although belonging to the class B scavenger receptor family, can recognize AGE proteins as ligands. This was tested at the cellular level in this study using Chinese hamster ovary (CHO) cells overexpressing hu man CD36 (CD36-CHO cells). Cellular expression of CD36 was confirmed by immunoblotting and immunofluorescent microscopy using anti-CD36 antibody; Upon incubation at 37 degreesC, I-125-AGE-bovine serum albumin (AGE-BSA) and I-125-oxidized low density lipoprotein (LDL), an authentic ligand for CD36, were endocytosed in a dose-dependent fashion and underwent lysosomal degradation by CD36-CHO cells, but not wildtype CHO cells. In binding experiments at 4 degreesC, I-125-AGE-BSA exhibited specific and saturable binding to CD36-CHO cells (K-d = 5.6 mug/ml). The endocytic uptake of I-125-AGE-BSA by these cells was inhibited by 50% by oxidized LDL and by 60% by FA6-152, an anti-CD36 antibody inhibiting cellular binding of oxidized LDL. Our results indicate that CD36 expressed by these cells mediates the endocytic uptake and subsequent intracellular degradation of AGE proteins. Since CD36 is one of the major oxidized LDL receptors and is up-regulated in macrophage- and smooth muscle cell-derived foam cells in human atherosclerotic lesions, these results suggest that, like oxidized LDL, AGE proteins generated in situ are recognized by CD36, which might contribute to the pathogenesis of diabetic macrovascular complications.
引用
收藏
页码:3195 / 3202
页数:8
相关论文
共 73 条
[31]  
MAILLARD LC, 1992, C R ACAD SCI PARIS 3, V154, P66
[32]  
MAKITA Z, 1992, J BIOL CHEM, V267, P5133
[33]   Expression of macrophage (Mφ) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-γ, which regulates gain of Mφ-like phenotype in vitro, and its implication in atherogenesis [J].
Matsumoto, K ;
Hirano, K ;
Nozaki, S ;
Takamoto, A ;
Nishida, M ;
Nakagawa-Toyama, Y ;
Janabi, MY ;
Ohya, T ;
Yamashita, S ;
Matsuzawa, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) :1027-1032
[34]   EFFICIENT TRACE-LABELLING OF PROTEINS WITH IODINE [J].
MCFARLANE, AS .
NATURE, 1958, 182 (4627) :53-53
[35]   IMMUNOCHEMICAL DETECTION OF ADVANCED GLYCATION END-PRODUCTS IN RENAL-CORTEX FROM STZ-INDUCED DIABETIC RAT [J].
MITSUHASHI, T ;
NAKAYAMA, H ;
ITOH, T ;
KUWAJIMA, S ;
AOKI, S ;
ATSUMI, T ;
KOIKE, T .
DIABETES, 1993, 42 (06) :826-832
[36]   BETA(2)-MICROGLOBULIN MODIFIED WITH ADVANCED GLYCATION END-PRODUCTS IS A MAJOR COMPONENT OF HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS [J].
MIYATA, T ;
ODA, O ;
INAGI, R ;
IIDA, Y ;
ARAKI, N ;
YAMADA, N ;
HORIUCHI, S ;
TANIGUCHI, N ;
MAEDA, K ;
KINOSHITA, T .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1243-1252
[37]   INVOLVEMENT OF BETA(2)-MICROGLOBULIN MODIFIED WITH ADVANCED GLYCATION END-PRODUCTS IN THE PATHOGENESIS OF HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS - INDUCTION OF HUMAN MONOCYTE CHEMOTAXIS AND MACROPHAGE SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1 [J].
MIYATA, T ;
INAGI, R ;
IIDA, Y ;
SATO, M ;
YAMADA, N ;
ODA, O ;
MAEDA, K ;
SEO, H .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :521-528
[38]   Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor [J].
Nagai, R ;
Matsumoto, K ;
Ling, X ;
Suzuki, H ;
Araki, T ;
Horiuchi, S .
DIABETES, 2000, 49 (10) :1714-1723
[39]   Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ [J].
Nagy, L ;
Tontonoz, P ;
Alvarez, JGA ;
Chen, HW ;
Evans, RM .
CELL, 1998, 93 (02) :229-240
[40]  
NAITO M, 1992, AM J PATHOL, V141, P591